Procedure for assessing the acceptability, in principle, of vaccines ...

References
1. Procedure for assessing the acceptability in principle of vaccines proposed to
United Nations agencies for use in immunization programmes (revised 1988). Annex
1, in: WHO Expert Committee on Biological Standardization. Thirty-ninth Report.
Geneva, World Health Organization, 1989 (WHO Technical Report Series, No. 786).
2. Vaccine indicators (revised 2007). Geneva, World Health Organization, 2010
(http://www.who.int/immunization_standards/national_regulatory_authorities%
20/vaccine_indicators/en/index.html/, accessed 18 January 2012).
3. WHO prequalified vaccines (database). Geneva, World Health Organization
(http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_e
n/en/index.html, accessed 18 January 2012).
4. Priority setting for WHO vaccine prequalification. Geneva, World Health
Organization, 2011
(http://www.who.int/immunization_standards/vaccine_quality/pq_priorities/en/i
ndex.html, accessed 18 January 2012).
5. Assessing the programmatic suitability of vaccine candidates for WHO
prequalification. Geneva, World Health Organization, 2010
(http://www.who.int/immunization_standards/vaccine_quality/pspqwg1_draft4_
27oct2010.pdf, accessed 18 January 2012).
6. Guideline on procedural aspects regarding a CHMP scientific opinion in the
context of cooperation with the World Health Organization (WHO) for the evaluation
of medicinal products intended exclusively for markets outside the community.
London, European Medicines Agency (Guideline
EMEA/CHMP/5579/04 on Article 58)
(http://www.emea.europa.eu/pdfs/human/regaffair/557904en.pdf).
7. Note for guidance to manufacturers of prequalified vaccines. Geneva, World
Health Organization (in preparation).
8. WHO prequalification: information and guidance documents for vaccine
manufacturers. Geneva, World Health Organization
(http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_man
ufacturers_guidance/en/index.html, accessed 18 January 2012).
44